114 related articles for article (PubMed ID: 22460030)
1. New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell line.
Kim HJ; Cho HJ; Kim H; El-Gamal MI; Oh CH; Lee SH; Sim T; Hah JM; Yoo KH
Bioorg Med Chem Lett; 2012 May; 22(9):3269-73. PubMed ID: 22460030
[TBL] [Abstract][Full Text] [Related]
2. New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies.
Koh EJ; El-Gamal MI; Oh CH; Lee SH; Sim T; Kim G; Choi HS; Hong JH; Lee SG; Yoo KH
Eur J Med Chem; 2013; 70():10-21. PubMed ID: 24128410
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2.
Jung MH; El-Gamal MI; Abdel-Maksoud MS; Sim T; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2012 Jul; 22(13):4362-7. PubMed ID: 22647720
[TBL] [Abstract][Full Text] [Related]
5. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2015 Apr; 25(8):1692-1699. PubMed ID: 25801936
[TBL] [Abstract][Full Text] [Related]
7. New triarylpyrazoles as broad-spectrum anticancer agents: design, synthesis, and biological evaluation.
El-Gamal MI; Park YS; Chi DY; Yoo KH; Oh CH
Eur J Med Chem; 2013 Jul; 65():315-22. PubMed ID: 23732996
[TBL] [Abstract][Full Text] [Related]
8. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.
El-Gamal MI; Park BJ; Oh CH
Eur J Med Chem; 2018 Aug; 156():230-239. PubMed ID: 30006168
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group.
Yao P; Zhai X; Liu D; Qi BH; Tan HL; Jin YC; Gong P
Arch Pharm (Weinheim); 2010 Jan; 343(1):17-23. PubMed ID: 19927308
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma.
Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.
Zhao CR; Wang RQ; Li G; Xue XX; Sun CJ; Qu XJ; Li WB
Bioorg Med Chem Lett; 2013 Apr; 23(7):1989-92. PubMed ID: 23454017
[TBL] [Abstract][Full Text] [Related]
17. A new series of diarylamides possessing quinoline nucleus: Synthesis, in vitro anticancer activities, and kinase inhibitory effect.
El-Gamal MI; Khan MA; Abdel-Maksoud MS; Gamal El-Din MM; Oh CH
Eur J Med Chem; 2014 Nov; 87():484-92. PubMed ID: 25282271
[TBL] [Abstract][Full Text] [Related]
18. Novel diarylamides and diarylureas with N-substitution dependent activity against medulloblastoma.
Lawson C; Ahmed Alta TB; Moschou G; Skamnaki V; Solovou TGA; Topham C; Hayes J; Snape TJ
Eur J Med Chem; 2021 Dec; 225():113751. PubMed ID: 34391032
[TBL] [Abstract][Full Text] [Related]
19. 1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitors.
Yu H; Jung Y; Kim H; Lee J; Oh CH; Yoo KH; Sim T; Hah JM
Bioorg Med Chem Lett; 2010 Jun; 20(12):3805-8. PubMed ID: 20466542
[TBL] [Abstract][Full Text] [Related]
20. Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells.
Kim MH; Kim M; Yu H; Kim H; Yoo KH; Sim T; Hah JM
Bioorg Med Chem; 2011 Mar; 19(6):1915-23. PubMed ID: 21353571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
